Bridgefront Capital’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$251K	Buy	+4,545	New	+$251K	0.07%	488
2024 Q1	–	Sell	-11,370	Closed	-$261K	–	525
2023 Q4	$261K	Buy	+11,370	New	+$261K	0.2%	207
2022 Q4	–	Sell	-12,084	Closed	-$102K	–	487
2022 Q3	$102K	Buy	+12,084	New	+$102K	0.1%	276